Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Michael F Morris , Philip A Araoz Added: 3 years ago
Mitral valve dysfunction is the most common cause of valvular disease in the US.1 Although echocardiography is the primary non-invasive modality for visualizing the mitral valve, advances in technology continue to allow for improved evaluation of mitral disease with magnetic resonance imaging (MRI) and computed tomography (CT).2,3 Currently, the role for MRI and CT assessment of the mitral valve… View more

Vascular Disease and Surgery

Imaging & Diagnostics
TAVR Optimization
Author(s): Saima Siddique , Resha Khanal , Amit N Vora , et al Added: 2 years ago

Vascular Disease and Surgery

Intervention
TCT 22: Sentinel® Stroke Protection System During TAVR
Author(s): Samir R Kapadia Added: 1 year ago
TCT 22 - In this short interview, Dr Samir Kapadia (Cleveland Clinic, OH, US) outlines the findings of the PROTECTED-TAVR trial, which aimed to demonstrate the performance of Boston Scientific's Sentinel® Cerebral Protection System in transcatheter aortic valve replacement. In this study, 3000 patients were randomized to receive either TAVR with the Sentinel system or TAVR without intervention… View more

Prevention & Chronic Conditions

Intervention
Author(s): Jeffrey L Turner , Nassir F Marrouche Added: 3 years ago
The incidence of AF is on the rise.1–3 This is secondary not only to increasing prevalence but also a focus on increased recognition of occult AF for primary thromboembolic (TE) prevention.4 How we identify and treat these patients with AF is constantly in flux. While it is possible that a novel procedure or antiarrhythmic drug could create sweeping changes in AF management overnight, here we… View more

Electrophysiology & Arrhythmia
Who should be referred for TAVR
Author(s): Colin M Barker , Michael J Reardon Added: 3 years ago
Aortic stenosis (AS) has a long latent period and then rapid progression with high mortality once symptoms appear.1 The absence of an effective medical therapy for symptomatic severe AS led to a class I indication for aortic valve replacement (AVR) in both the US and European guidelines.2,3 Unfortunately, a study by Bach et al. in 2009 found that up to half of patients with symptomatic severe AS… View more

Vascular Disease and Surgery

Intervention
Vascular Access Management of Complex High Risk Interventional Procedures
Author(s): Jimmy Kerrigan , Timir K Paul , Jay Patel , et al Added: 6 months ago

Intervention
TAVR Versus SAVR in Young, Low-risk Patients
Author(s): Quynh Nguyen , Jessica GY Luc , Thomas E MacGillivray , et al Added: 1 year ago

Vascular Disease and Surgery

Intervention
Mechanical Circulatory Support for Complex High-risk PCI
Author(s): Alexander G Truesdell , Rhian E Davies , Moemen Eltelbany , et al Added: 1 year ago

Heart Failure

Intervention
Author(s): Shanmugam Uthamalingam , James L Januzzi Added: 3 years ago
Several cardiac biomarkers may aid in the diagnostic and prognostic evaluation of acute and chronic heart failure. In this article we discuss more novel and emerging applications of such established cardiac biomarkers in heart failure and review emerging data for several other promising markers. Novel Applications of Established Cardiac Biomarkers—Natriuretic Peptides B-type natriuretic peptide… View more

Heart Failure

MI/ACS
Author(s): Ahmad Younes , Guilherme Ferragut Attizzani , Ankur Kalra Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) is a recent innovation that has transformed the care of patients with symptomatic severe aortic stenosis. It has emerged as an alternative for surgical aortic valve replacement (SAVR) in prohibitive-, high-risk, and more recently, intermediate-risk surgical patients. More than 200,000 TAVRs have been performed in 65 countries around the world.1 As… View more

Vascular Disease and Surgery

Intervention